Magnetic nanoparticle compositions and methods
A nanoparticle having a core comprising a magnetic material and surface to which are covalently coupled a plurality of silane moieties, wherein each silane moiety comprises a polyalkylene oxide moiety. The nanoparticle can further include a targeting agent, a targeting agent and a diagnostic agent, or a targeting agent and a therapeutic agent. Methods for using the nanoparticle to detect and treat tissues of interest.
1. A nanoparticle, comprising:
(a) a core comprising a magnetic material and having a surface; and
(b) a plurality of silane moieties, wherein each silane moiety is covalently coupled to the surface, wherein at least a portion of the plurality of silane moieties comprises a targeting agent, and wherein the plurality of silane moieties comprising the targeting agent have the formula:
wherein,
n is 1, 2, 3, 4, 5, or 6;
m is an integer from about 10 to about 1000;
L is a direct bond or a linker; and
T is the targeting agent.
2. The nanoparticle of claim 1 , wherein at least a portion of the plurality of silane moieties comprise a therapeutic agent.
3. The nanoparticle of claim 1 , wherein at least a portion of the plurality of silane moieties comprise a fluorescent agent.
4. The nanoparticle of claim 1 , wherein at least a portion of the plurality of silane moieties comprise a radiolabel.
5. The nanoparticle of claim 1 , wherein the targeting agent is selected from the group consisting of a peptide, a protein, and a nucleic acid.
6. A composition, comprising a nanoparticle of claim 1 suitable for administration to a human subject.
7. A method for detecting cells or tissues by magnetic resonance imaging, comprising:
(a) contacting cells or tissues of interest with a nanoparticle having affinity and specificity for the cells or tissues of interest, wherein the nanoparticle comprises
(i) a core comprising a magnetic material and having a surface, and
(ii) a plurality of silane moieties,
wherein each silane moiety is covalently coupled to the surface,
wherein at least a portion of the plurality of silane moieties comprises a targeting agent having affinity and specificity to the cells or tissues of interest, and wherein the plurality of silane moieties comprising the targeting agent have the formula:
wherein,
n is 1, 2, 3, 4, 5, or 6,
m is an integer from about 10 to about 1000,
L is a direct bond or a linker, and
T is the targeting agent; and
(b) measuring the level of binding of the nanoparticle, wherein an elevated level of binding, relative to normal cells or tissues, is indicative of binding to the cells or tissues of interest.